tibulizumab
tibulizumab: sourced relationships with 1 company · 1 clinical trial tracked.
tibulizumab evidence translation
What we can confirm
1 tracked trial
What it means
What to watch
Prepared research question
How could tibulizumab → ZURA affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Zura Bio Ltd (ZURA) Systemic Sclerosis (SSc) | Phase 2 |
Clinical Trial Registry Records (1)
A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Systemic Sclerosis
Primary endpoint: [Period 1] Change from baseline in modified Rodnan Skin Score (mRSS) at 24 weeks
Frequently asked questions
Which companies have sourced relationships with tibulizumab?
tibulizumab has dated SEC/FDA relationship records for Zura Bio Ltd.
How many clinical trials involve tibulizumab?
BioSniper tracks 1 clinical trial involving tibulizumab.